# DurAVR™ THV EU-EFS

> **NCT06510855** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Anteris Technologies Ltd.** · enrollment: 40 (estimated)

## Conditions studied

- Symptomatic Aortic Stenosis
- Severe Aortic Valve Stenosis
- Aortic Valve Calcification
- Aortic Valve Failure
- Aortic Valve Disease

## Interventions

- **DEVICE:** DurAVR™ THV System

## Key facts

- **NCT ID:** NCT06510855
- **Lead sponsor:** Anteris Technologies Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-01-21
- **Primary completion:** 2026-07
- **Final completion:** 2031-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06510855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06510855, "DurAVR™ THV EU-EFS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06510855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*